[Compounded Ketamine: Innovative Support for Pain and Mood Disorders]

Ketamine, originally developed as an anesthetic

has gained recognition in recent years for its potential to help individuals with difficult-to-treat conditions when standard therapies have not provided sufficient relief with difficult-to-treat conditions when standard therapieshave not provided sufficient relief, We work closely with prescribers to compound ketamine formulations to support patients facing chronic pain and treatment-resistant mood disorders

[Compounded Dosage Forms]

Available Compounded Dosage Forms:

  1. Sublingual Troches or Lozenges
  2. Nasal Sprays
  3. Topical Creams and Gels

Ketamine exerts its therapeutic effects through multiple pathways, making it uniquely effective for both pain management and mood disorders:

  • NMDA Receptor Antagonism: Ketamine blocks N-methyl-D-aspartate (NMDA) receptors in the brain and spinal cord, which helps reduce central sensitization and chronic pain signaling
  • Glutamate Modulation: By increasing glutamate levels in the brain, ketamine promotes synaptic plasticity and neural regeneration, which may improve symptoms of depression, PTSD, and anxiety
  • AMPA Receptor Activation: This downstream effect enhances mood regulation by promoting faster-acting antidepressant effect
  • Opioid Receptor Interaction: Ketamine may have mild interaction with opioid receptors, contributing to its analgesic properties without typical opioid side effects
  • Anti-inflammatory Effects: It may help reduce neuroinflammation, which has been linked to both chronic pain and mood disorders

Conditions That May Benefit from Compounded Ketamine:

  • Chronic Pain Syndromes
    (e.g., Complex Regional Pain Syndrome, Neuropathic Pain, Fibromyalgia)
  • Major Depressive Disorder (MDD)
  • Treatment-Resistant Depression (TRD)
  • Anxiety Disorders
  • Post-Traumatic Stress Disorder (PTSD)
  • Bipolar Depression
  • Migraines and Cluster Headaches